Effect of
GST genetic polymorphisms
busulfan
hematopoietic stem-cell transplantation pharmacokinetics
pediatric Asians
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
11 Feb 2022
11 Feb 2022
Historique:
received:
09
12
2021
revised:
04
02
2022
accepted:
07
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
27
2
2022
Statut:
epublish
Résumé
Busulfan is widely used as a chemotherapy treatment before hematopoietic stem-cell transplantation (HSCT). However, the response of busulfan is highly variable and unpredictable, whereby the pharmacogenetic interference of glutathione
Identifiants
pubmed: 35214132
pii: pharmaceutics14020401
doi: 10.3390/pharmaceutics14020401
pmc: PMC8880478
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Biol Chem. 1998 Feb 6;273(6):3517-27
pubmed: 9452477
Biol Blood Marrow Transplant. 2009 Feb;15(2):231-41
pubmed: 19167683
BMC Pediatr. 2020 Apr 20;20(1):176
pubmed: 32312247
Toxicol Sci. 2006 Feb;89(2):438-43
pubmed: 16280386
Biol Blood Marrow Transplant. 2012 Feb;18(2):265-72
pubmed: 21736869
Oncology. 2004;67(5-6):368-75
pubmed: 15713992
Biol Blood Marrow Transplant. 2011 Aug;17(8):1222-30
pubmed: 21215809
Cancer Res Treat. 2016 Jul;48(3):948-54
pubmed: 26790968
Int J Hematol. 2020 Jan;111(1):84-92
pubmed: 31555969
Pharmacogenetics. 2002 Jun;12(4):277-86
pubmed: 12042665
Cancer Chemother Pharmacol. 1993;33(3):181-6
pubmed: 8269597
Blood. 2013 Dec 5;122(24):3856-7
pubmed: 24311716
Mutat Res. 2001 Oct 1;482(1-2):21-6
pubmed: 11535245
Cancer Chemother Pharmacol. 2020 Feb;85(2):293-308
pubmed: 31834435
Endocrinology. 2004 Jan;145(1):311-7
pubmed: 14551226
Clin Chem Lab Med. 2004 May;42(5):560-2
pubmed: 15202795
Biol Blood Marrow Transplant. 2013 Jul;19(7):1033-9
pubmed: 23583825
Biochem J. 1998 Jun 15;332 ( Pt 3):763-8
pubmed: 9620880
Blood. 2010 Jun 3;115(22):4597-604
pubmed: 20237319
Bone Marrow Transplant. 2010 Feb;45(2):261-7
pubmed: 19584821
Expert Opin Drug Metab Toxicol. 2017 Sep;13(9):901-923
pubmed: 28766962
Oncotarget. 2017 Aug 27;8(53):90852-90867
pubmed: 29207608
Biol Blood Marrow Transplant. 2017 Nov;23(11):1918-1924
pubmed: 28807770
Bone Marrow Transplant. 2018 Feb;53(2):138-145
pubmed: 28759025
J Clin Pharmacol. 2011 Oct;51(10):1429-38
pubmed: 21135089
Bone Marrow Transplant. 2012 Feb;47(2):190-5
pubmed: 21441958
Pharmacogenet Genomics. 2013 Dec;23(12):675-83
pubmed: 24192531
Front Genet. 2017 Oct 31;8:167
pubmed: 29163635
Pharmacogenomics. 2013 Nov;14(14):1683-90
pubmed: 24192117
Stem Cells Cloning. 2010 Aug 26;3:105-17
pubmed: 24198516
Front Immunol. 2020 Apr 03;11:489
pubmed: 32318059
J Clin Pharmacol. 2008 Sep;48(9):1052-62
pubmed: 18635758
Ther Drug Monit. 2015 Aug;37(4):493-500
pubmed: 25565670
J Assist Reprod Genet. 2014 Mar;31(3):379-82
pubmed: 24390679
Blood. 2013 Dec 5;122(24):3871-8
pubmed: 24081656
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 May 15;1145:122091
pubmed: 32315975
Pharmacogenomics. 2015;16(14):1585-94
pubmed: 26419450
Cancer Chemother Pharmacol. 2006 Jan;57(2):191-8
pubmed: 16133536
Biochem Biophys Res Commun. 1986 Oct 30;140(2):581-8
pubmed: 3778469
Drug Metab Dispos. 1996 Sep;24(9):1015-9
pubmed: 8886613
Biol Blood Marrow Transplant. 2007 Jul;13(7):853-62
pubmed: 17580264
Pediatr Int. 2019 Jun;61(6):558-565
pubmed: 30963629
J Clin Pharmacol. 2013 Nov;53(11):1205-11
pubmed: 23955479
Pharmacogenomics J. 2014 Jun;14(3):263-71
pubmed: 24165757
Bone Marrow Transplant. 2015 May;50(5):696-705
pubmed: 25730183
Clin Chim Acta. 2006 Jun;368(1-2):93-8
pubmed: 16448639
Br J Clin Pharmacol. 2018 Jul;84(7):1494-1504
pubmed: 29469189
Biol Blood Marrow Transplant. 2008 Feb;14(2):220-8
pubmed: 18215782
Arch Toxicol. 2007 Nov;81(11):777-84
pubmed: 17503020
Biol Blood Marrow Transplant. 2018 Apr;24(4):726-733
pubmed: 29197676
J Pharmacol Sci. 2009 Dec;111(4):440-5
pubmed: 20019448
Pharmaceutics. 2019 Sep 01;11(9):
pubmed: 31480560
Pediatr Blood Cancer. 2010 Dec 1;55(6):1172-9
pubmed: 20672371